Apcotex Industries DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Sep 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.76×0.75×0.71×0.72×0.74×
1.01×1.05×0.92×0.90×1.02×
12.6%8.9%6.0%7.3%13.3%
1.45×1.45×1.45×1.30×1.53×
1.63×1.59×1.81×1.77×1.69×
23.0%16.2%10.2%11.0%25.8%
17.3%17.3%10.1%10.8%24.8%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

APCOTEXIND₹520.00

Apcotex Industries Limited

· Capital Goods & Defence
₹ CrorePeersPIXTRANSTINNARUBRGRPLTDRUBFILAHARRMALAYASAMPANNMcap ₹2,696 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.740.720.710.750.76
Interest Burden (Pretax/EBIT) ×1.020.900.921.051.01
EBIT Margin %13.277.335.978.8712.63
Asset Turnover ×1.531.301.451.451.45
Financial Leverage (Assets/Equity) ×1.691.771.811.591.63
ROE (5-step product, year-end total equity) %25.8111.0110.1716.2023.02
ROE (owners' profit / average owners' equity) %24.7510.8010.0617.2717.27
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.